Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

No treatment fully prevents hair loss from chemotherapy yet.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

New treatments for hair loss are being developed using molecular biology.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Quercetin effectively treated and prevented hair loss in mice.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Nanocarriers make melatonin more effective and reduce side effects.

Misinformation about alopecia can lead to poor treatment, so it's important for healthcare professionals to correct myths.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Magnetic nanovesicles from stem cells can improve hair growth by staying in the skin longer.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Chemical peels are effective and popular for treating men's skin issues, with some special considerations for their unique skin needs.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document is a detailed medical reference on skin and genetic disorders.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Effective symptom management in IBD improves quality of life and prevents complications.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

A new treatment using microneedles with black phosphorus and laser helps regrow hair effectively and safely.